Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Home
Search
PMID 40408124

Semaglutide Improves Severe Liver Disease in Phase 3 Trial.

JAMA2025PMID: 40408124

View on PubMed DOI: 10.1001/jama.2025.6462

Authors

Anderer, Samantha

Semaglutide Improves Severe Liver Disease in Phase 3 Trial. | Pepdox